Welcome to CDC stacks | CDC : 40 years of prevention - 21421 | David J. Sencer CDC Museum
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
CDC : 40 years of prevention
  • Published Date:
    June 1986
  • Source:
    Dateline: CDC ; v. 18, no. 5, rev.
  • Language:
    English
Filetype[PDF-7.60 MB]


This document cannot be previewed automatically as it exceeds 5 MB
Please click the thumbnail image to view the document.
CDC : 40 years of prevention
Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Colonoscopy Screening Among US Adults Aged 40 or Older With a Family History of Colorectal Cancer
    Personal Author:
    Tsai, Meng-Han; Xirasagar, Sudha; Li, Yi-Jhen; de Groen, Piet C.;
    Published:
    May 21 2015
    Source:
    Prev Chronic Dis. 12.
    Description:
    Introduction : Colonoscopy screening reduces colorectal cancer (CRC) incidence and mortality. CRC screening is recommended at age 50 for average-risk people. Screening of first-degree relatives of CRC patients is recommended to begin at age 40 or 10 ...
    File Type:
    Filetype[PDF - 304.80 KB]
  2. Update on recommendations for use of herpes zoster vaccine
    Personal Author:
    Hales, Craig M.; Harpaz, Rafael; Ortega-Sanchez, Ismael; Bialek, Stephanie R.;
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.; National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.;
    Published:
    August 22, 2014
    Series:
    MMWR. Morbidity and mortality weekly report, Vol. 63, no. 33, p. 729-31
    Description:
    Herpes zoster vaccine (Zostavax [Merck & Co., Inc.]) was licensed in 2006 and recommended by the Advisory Committee on Immunization Practices (ACIP) in 2008 for prevention of herpes zoster (shingles) and its complications among adults aged ≥60 year...
    Status:
    current
    File Type:
    Filetype[PDF - 195.85 KB]
  3. Update on Recommendations for Use of Herpes Zoster Vaccine
    Personal Author:
    Hales, Craig M.; Harpaz, Rafael; Ortega-Sanchez, Ismael; Bialek, Stephanie R.;
    Published:
    Aug 22 2014
    Source:
    MMWR Morb Mortal Wkly Rep. 2014; 63(33):729-731.
    Description:
    Herpes zoster vaccine (Zostavax [Merck & Co., Inc.]) was licensed in 2006 and recommended by the Advisory Committee on Immunization Practices (ACIP) in 2008 for prevention of herpes zoster (shingles) and its complications among adults aged ≥60 year...
    File Type:
    Filetype[PDF - 109.32 KB]
  4. Adolescent health in the United States, 2007
    Personal Author:
    MacKay, Andrea P.; Duran, Catherine;
    Corporate Author:
    National Center for Health Statistics (U.S.), Office of Analysis and Epidemiology.
    Published:
    December 2007
    Series:
    DHHS publication ; no. 2008-1034
    Description:
    "Adolescent Health in the United States, 2007 was prepared by Andrea P. MacKay and Catherine Duran of the Office of Analysis and Epidemiology, National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC)." - p. iii
    File Type:
    Filetype[PDF - 1.52 MB]
  5. Mammography rates after the 2009 revision to the United States Preventive Services Task Force breast cancer screening recommendation
    Personal Author:
    Qin, Xuanzi; Tangka, Florence K.L.; Guy, Gery P.; Howard, David H.;
    Published:
    Dec 26 2016
    Source:
    Cancer Causes Control. 28(1):41-48.
    Description:
    Background : In 2009, the United States Preventive Services Task Force (USPSTF) recommended against routine mammography screening for women aged 40–49 years. This revised recommendation was widely criticized and has sparked off intense debate. The ...
    File Type:
    Filetype[PDF - 303.79 KB]